Good News: HymonBio Has Received Myanmar FDA Certification!


Good News: HymonBio Has Received Myanmar FDA Certification!

With its profound technical strength, HymonBio has helped to fight the epidemic. And now, more good news: The HymonBio® SARS-CoV-2 Test Kit has been certified by the Myanmar FDA. This is a new market expansion for Hymon after obtaining the FDA EUA and EU CE certification.


The HymonBio® SARS-CoV-2 Test Kit, developed independently, has been certified by the Myanmar FDA, indicating our products meet the requirements of relevant instructions in Myanmar, and have completed the registration with the proper authorities. This is the first step to open the Myanmar market. At the same time, it also provides quality assurance for the sales of products in the domestic market and enhances the brand influence of products.

Advantages of SARS-CoV-2 Test Kit

Received the FDA EUA certification, and cited by the FDA commissioner.

Rapid detection: Innovative and exclusive one-step method completes RNA processing in 3 minutes, with sample-to-results in 35 minutes.

Multiple monitoring: The original DIDC double internal standard technology carries out the entire process of quality control of the sample quality and testing.

Unique technology: Nanobody molecular locking technology (MoLock)  improves sensitivity and specificity.

Passed quality evaluation of many clinical institutions, including: American Reference Laboratory, Kenya National Laboratory, Shanghai Clinical Testing Center, Jiangsu Medical Device Inspection Institute, etc.


COVID-19 is still in an important stage of prevention and control. Timely and accurate diagnosis can effectively control the spread of COVID-19 epidemic. HymonBio is rooted in China, providing accurate and rich COVID-19 detection products for international epidemic prevention and control.

Post time: Apr-12-2022